Literature DB >> 33407911

Legionnaires' disease in the time of COVID-19.

Kelsie Cassell1, J Lucian Davis2,3, Ruth Berkelman4.   

Abstract

Due to similarities in initial disease presentation, clinicians may be inclined to repeatedly test community-acquired pneumonia cases for COVID-19 before recognizing the need to test for Legionnaires' disease. Legionnaires' disease is an illness characterized by pneumonia that has a summer/early fall seasonality due to favorable conditions for Legionella growth and exposure. Legionella proliferate in warm water environments and stagnant sections of indoor plumbing and cooling systems. During the ongoing pandemic crisis, exposures to aerosolized water from recently reopened office or retail buildings should be considered as an epidemiologic risk factor for Legionella exposure and an indication to test. The majority of Legionnaires' disease cases occurring each year are not diagnosed, and some experts recommend that all patients hospitalized with community-acquired pneumonia without a known etiology be tested for Legionella infection. Proper diagnosis can increase the likelihood of appropriate and timely antibiotic treatment, identify potential clusters of disease, and facilitate source attribution.

Entities:  

Keywords:  COVID-19; Epidemiology; Legionnaires’ disease

Year:  2021        PMID: 33407911     DOI: 10.1186/s41479-020-00080-5

Source DB:  PubMed          Journal:  Pneumonia (Nathan)        ISSN: 2200-6133


  7 in total

1.  Legionella pneumophila Risk from Cooling Tower Systems in China.

Authors:  Tian Qin; Dahui Zhao; Li Zhu; Hongyu Ren; Yinan Li; Xinjun Liu; Xiaopeng Li; Wei Li; Na Zhao; Jiao Lu; Di Liu; Yi Shi; Min Fang; Xuefeng Duan
Journal:  Appl Environ Microbiol       Date:  2021-11-24       Impact factor: 5.005

2.  Investigation of a cluster of Legionnaires' disease during the outbreak of coronavirus disease 2019 pandemic in northeastern Taiwan, June 2021.

Authors:  Jung-Jr Ye; Jun-Yuan Zheng; Ya-Hsuan Chen; Ya-Ling Kao; Yu-Chin Kao; Shao-Wen Chao
Journal:  J Microbiol Immunol Infect       Date:  2022-05-05       Impact factor: 10.273

3.  Impact of lockdown and non-pharmaceutical interventions on the epidemiology of Legionnaires' disease.

Authors:  Matteo Riccò
Journal:  Acta Biomed       Date:  2022-03-14

4.  I'm dreaming of a COVID-free Christmas.

Authors:  Abigail Sawyer; Tristan Free; Ebony Torrington
Journal:  Biotechniques       Date:  2021-12-02       Impact factor: 1.993

5.  Vaccinomics to Design a Multiepitope Vaccine against Legionella pneumophila.

Authors:  Ahitsham Umar; Sadia Liaquat; Israr Fatima; Abdur Rehman; Danish Rasool; Abdulrahman Alshammari; Metab Alharbi; Muhammad Shahid Riaz Rajoka; Mohsin Khurshid; Usman Ali Ashfaq; Asma Haque
Journal:  Biomed Res Int       Date:  2022-09-17       Impact factor: 3.246

6.  A Prolonged Neurological Presentation of Legionnaire's Disease.

Authors:  Shaorinkumar Patel; Radhika Sharma; Barrett O Attarha; Pramod Reddy
Journal:  Cureus       Date:  2021-06-15

Review 7.  SARS-CoV-2-Legionella Co-Infections: A Systematic Review and Meta-Analysis (2020-2021).

Authors:  Matteo Riccò; Pietro Ferraro; Simona Peruzzi; Alessandro Zaniboni; Silvia Ranzieri
Journal:  Microorganisms       Date:  2022-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.